BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almallah YZ, Ewen SW, El-Tahir A, Mowat NA, Brunt PW, Sinclair TS, Heys SD, Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol. 2000;20:68-76. [PMID: 10798610 DOI: 10.1023/A:1006698728816] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Papadia C, Coruzzi A, Montana C, Di Mario F, Franzè A, Forbes A. Omega-3 fatty acids in the maintenance of ulcerative colitis. JRSM Short Rep 2010;1:15. [PMID: 21103107 DOI: 10.1258/shorts.2010.010004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
2 Gil A. Is eicosapentaenoic acid useful in the treatment of ulcerative colitis in children? J Pediatr Gastroenterol Nutr 2003;37:536-7. [PMID: 14581792 DOI: 10.1097/00005176-200311000-00005] [Reference Citation Analysis]
3 Asbell PA, Maguire MG, Peskin E, Bunya VY, Kuklinski EJ; Dry Eye Assessment and Management (DREAM©) Study Research Group. Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics. Contemp Clin Trials 2018;71:70-9. [PMID: 29883769 DOI: 10.1016/j.cct.2018.06.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
4 Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey Smith G, Riemersma RA, Ebrahim SB. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004;:CD003177. [PMID: 15495044 DOI: 10.1002/14651858.CD003177.pub2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
5 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(13): 1577-1580 [DOI: 10.11569/wcjd.v13.i13.1577] [Reference Citation Analysis]
6 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
7 Khan I, Samson SE, Grover AK. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. Med Princ Pract 2017;26:201-17. [PMID: 28278495 DOI: 10.1159/000468988] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]